Palatin Technologies (NYSEAMERICAN:PTN – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Wednesday, February 12th. Analysts expect the company to announce earnings of ($0.42) per share for the quarter.
Palatin Technologies Stock Performance
Shares of NYSEAMERICAN:PTN opened at $0.80 on Wednesday. Palatin Technologies has a one year low of $0.68 and a one year high of $4.65. The stock has a market cap of $15.64 million, a P/E ratio of -0.40 and a beta of 0.87.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright restated a “buy” rating and set a $17.00 price objective on shares of Palatin Technologies in a research note on Tuesday, January 28th.
About Palatin Technologies
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.
Featured Stories
- Five stocks we like better than Palatin Technologies
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Investing in the High PE Growth Stocks
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- What is the Nikkei 225 index?
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
